Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
156,912,856
-
Share change
-
+1,396,492
-
Total reported value
-
$6,416,262,984
-
Put/Call ratio
-
165%
-
Price per share
-
$40.89
-
Number of holders
-
229
-
Value change
-
+$54,854,564
-
Number of buys
-
122
-
Number of sells
-
88
Institutional Holders of CEREVEL THERAPEUTICS HLDNG I - COM (CERE) as of Q2 2024
As of 30 Jun 2024,
CEREVEL THERAPEUTICS HLDNG I - COM (CERE) was held by
229 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
156,912,856 shares.
The largest 10 holders included
Bain Capital Investors LLC, PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, VANGUARD GROUP INC, BlackRock Inc., FIL Ltd, STATE STREET CORP, ALPINE ASSOCIATES MANAGEMENT INC., NORGES BANK, and Paradigm Biocapital Advisors LP.
This page lists
229
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.